{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:47:43Z","timestamp":1761511663576,"version":"3.37.3"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2003,12,30]],"date-time":"2003-12-30T00:00:00Z","timestamp":1072742400000},"content-version":"vor","delay-in-days":728,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Research Enhancement Award Program"},{"name":"Veterans Affairs, Washington, D.C."},{"name":"H.R.R."},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Portland VA Medical Center"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,1]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Hepatitis C virus (HCV) is the leading cause of chronic hepatitis, affecting approximately 2% of the world' population. The immune mechanisms responsible for the highly variable natural history in a given individual are unknown. We used a multiparameter flow cytometric technique to functionally and phenotypically characterize HCV-specific effector T cells in the peripheral blood of 32 individuals with different stages of hepatitis C disease (resolved, mild chronic, advanced chronic) and normal controls. We found the highest frequencies of virus-specific effector cells with an activated memory phenotype (CD45RO+CD69+) in subjects who had resolved HCV infection, either spontaneously or with antiviral therapy. Effector cells from patients with resolved infection produced Th1 type cytokines following stimulation with nonstructural antigens (NS3 and NS4), whereas effector cells from chronically infected patients produced Th1 type cytokines predominantly following stimulation with the HCV core antigen. Stimulation with superantigen staphylococcal enterotoxin (SEB) induced the same levels of cytokine production in the different patient groups. Among the HCV-seropositive patients, viral load inversely correlated with the Th1 effector cell response to NS3. Interleukin (IL)-4 was produced only in response to the control antigens, but not in response to the HCV recombinant proteins. Taken together, these findings suggest that a vigorous HCV-specific CD4+ Th1 response, particularly against the nonstructural proteins of the virus, may be associated with viral clearance and protection from disease progression. Prospective studies using this new flow cytometric assay will be required to determine whether antiviral therapy modifies the frequency, specificity, and function of these virus-specific effector cells.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1053\/jhep.2002.30293","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T03:46:10Z","timestamp":1030247170000},"page":"190-198","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":138,"title":["Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: Correlation with clinical disease stages"],"prefix":"10.1097","volume":"35","author":[{"given":"Hugo R.","family":"Rosen","sequence":"first","affiliation":[]},{"given":"Camette","family":"Miner","sequence":"additional","affiliation":[]},{"given":"Anna W.","family":"Sasaki","sequence":"additional","affiliation":[]},{"given":"David M.","family":"Lewinsohn","sequence":"additional","affiliation":[]},{"given":"Andrew J.","family":"Conrad","sequence":"additional","affiliation":[]},{"given":"Antony","family":"Bakke","sequence":"additional","affiliation":[]},{"given":"Archie H.G.","family":"Bouwer","sequence":"additional","affiliation":[]},{"given":"David J.","family":"Hinrichs","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"10.1053\/jhep.2002.30293-BIB1|cit1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1365-2893.1999.6120139.x","article-title":"Global surveillance and control of HCV.","volume":"6","author":"WHO Viral Hepatitis Prevention Board","year":"1999","journal-title":"J Viral Hepatol"},{"key":"10.1053\/jhep.2002.30293-BIB2|cit2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1086\/501752","article-title":"Primer on hepatitis C for hospital epidemiologists","volume":"21","author":"Rosen","year":"2000","journal-title":"Infection Control and Hospital Epidemiology"},{"key":"10.1053\/jhep.2002.30293-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1099\/0022-1317-81-7-1631","article-title":"Replication of hepatitis C virus","volume":"81","author":"Bartenschlager","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1053\/jhep.2002.30293-BIB4|cit4","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0891-5520(05)70130-6","article-title":"Viral hepatitis following liver transplantation","volume":"14","author":"Rosen","year":"2000","journal-title":"Infectious Disease Clinics of North America"},{"key":"10.1053\/jhep.2002.30293-BIB5|cit5","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0016-5085(93)90430-K","article-title":"T-lymphocyte response to hepatitis C virus in different clinical courses of infection","volume":"104","author":"Botarelli","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/jhep.2002.30293-BIB6|cit6","first-page":"790","article-title":"T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C virus infection and in healthy anti-hepatitis C virus-positive blood donors without viremia","volume":"24","author":"Lechmann","year":"1996","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.30293-BIB7|cit7","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/75063","article-title":"Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C","volume":"6","author":"Takaki","year":"2000","journal-title":"Nature Med"},{"key":"10.1053\/jhep.2002.30293-BIB8|cit8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI118842","article-title":"Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response","volume":"98","author":"Missale","year":"1996","journal-title":"J Clin Investigation"},{"key":"10.1053\/jhep.2002.30293-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1172\/JCI119338","article-title":"Determination of antigen-specific memory\/effector CD4+ T cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency","volume":"99","author":"Waldrop","year":"1997","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1053\/jhep.2002.30293-BIB10|cit10","first-page":"192A","article-title":"A randomized trial of daily versus b.i.d. interferon induction followed by combination rebetron therapy for HCV genotype 1 infection [Abstract]","volume":"30","author":"Rosen","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.30293-BIB11|cit11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/gast.1997.v112.pm9024300","article-title":"Morbidity and mortality in compensated cirrhosis type C: A retrospective followup study of 384 patients","volume":"112","author":"Fattovich","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/jhep.2002.30293-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/hep.510260637","article-title":"Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparison","volume":"26","author":"Tong","year":"1997","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.30293-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1099\/0022-1317-74-6-1093","article-title":"Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay","volume":"74","author":"Stuyver","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1053\/jhep.2002.30293-BIB14|cit14","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1099\/0022-1317-74-11-2391","article-title":"Classification of hepatitis C into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region","volume":"74","author":"Simmonds","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1053\/jhep.2002.30293-BIB15|cit15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1357-4310(99)01657-3","article-title":"Superantigens-powerful modifiers of the immune system","volume":"6","author":"Fraser","year":"2000","journal-title":"Molecular Medicine Today"},{"key":"10.1053\/jhep.2002.30293-BIB16|cit16","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4049\/jimmunol.165.2.925","article-title":"Mycobacterium tuberculosis-reactive CD8+ T lymphocytes: The relative contribution of classical versus nonclassical HLA restriction","volume":"165","author":"Lewinsohn","year":"2000","journal-title":"J Immunol"},{"key":"10.1053\/jhep.2002.30293-BIB17|cit17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/8400","article-title":"HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression","volume":"5","author":"Pitcher","year":"1999","journal-title":"Nature Med"},{"key":"10.1053\/jhep.2002.30293-BIB18|cit18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.7326\/0003-4819-132-4-200002150-00008","article-title":"Pathogenesis, natural history, treatment, and prevention of hepatitis C","volume":"132","author":"Liang","year":"2000","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/jhep.2002.30293-BIB19|cit19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4049\/jimmunol.150.2.353","article-title":"Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) cell clones and inhibits their antigen-specific proliferation and cytokine production","volume":"150","author":"Del Prete","year":"1993","journal-title":"J Immunol"},{"key":"10.1053\/jhep.2002.30293-BIB20|cit20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1089-3261(05)70317-2","article-title":"Virology of hepatitis C virus","volume":"1","author":"Fang","year":"1997","journal-title":"Clinics in Liver Disease"},{"key":"10.1053\/jhep.2002.30293-BIB21|cit21","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0016-5085(99)70353-7","article-title":"Recurrence of hepatitis C virus after loss of virus-specific CD4+ T cell response in acute hepatitis C","volume":"117","author":"Gerlach","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/jhep.2002.30293-BIB22|cit22","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","article-title":"Viral immune evasion due to persistence of activated T cells without effector function","volume":"188","author":"Zajac","year":"1998","journal-title":"J Exp Ed"},{"key":"10.1053\/jhep.2002.30293-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","article-title":"Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia","volume":"278","author":"Rosenberg","year":"1997","journal-title":"Science"},{"key":"10.1053\/jhep.2002.30293-BIB24|cit24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/gut.44.3.424","article-title":"Hepatitis C virus specific immune responses in anti-HCV positive patients without hepatitis C viremia","volume":"44","author":"Cramp","year":"1999","journal-title":"Gut"},{"key":"10.1053\/jhep.2002.30293-BIB25|cit25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/jhep.2001.21162","article-title":"Differential CD4+ and CD8+ T-cell responsiveness in hepatitis C virus infection","volume":"33","author":"Chang","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.30293-BIB26|cit26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.510290118","article-title":"Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum","volume":"29","author":"Dries","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.30293-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0140-6736(95)91691-1","article-title":"Possible mechanism involving T-lymphocyte responses to non-structural protein 3 in viral clearance in acute hepatitis C virus infection","volume":"346","author":"Diepolder","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.30293-BIB28|cit28","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0168-8278(98)80146-3","article-title":"The cellular immune responses induced in the followup of interferon-\u03b1 treated patients with chronic hepatitis C may determine the therapy outcome","volume":"29","author":"Lohr","year":"1998","journal-title":"J Hepatol"},{"key":"10.1053\/jhep.2002.30293-BIB29|cit29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1074-7613(00)80044-8","article-title":"Analysis of a successful immune response against hepatitis C virus","volume":"10","author":"Cooper","year":"1999","journal-title":"Immunity"},{"key":"10.1053\/jhep.2002.30293-BIB30|cit30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1084\/jem.178.1.17","article-title":"Compartmentalization of T-lymphocytes to the site of the disease: intrahepatic CD4+ T-cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C","volume":"178","author":"Minutello","year":"1993","journal-title":"J Exp Med"},{"key":"10.1053\/jhep.2002.30293-BIB31|cit31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0168-8278(99)80371-7","article-title":"Immunopathogenesis of hepatitis C virus infection","volume":"31","author":"Ferrari","year":"1999","journal-title":"J Hepatology"},{"key":"10.1053\/jhep.2002.30293-BIB32|cit32","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1053\/jhep.2000.9635","article-title":"Liver-derived hepatitis C virus (HCV)-specific CD4+ T cells recognize multiple HCV epitopes and produce interferon gamma","volume":"32","author":"Schirren","year":"2000","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.30293-BIB33|cit33","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0167-5699(96)80906-6","article-title":"Strange brew: T cells in the liver","volume":"17","author":"Crispe","year":"1996","journal-title":"Immunology Today"},{"key":"10.1053\/jhep.2002.30293-BIB34|cit34","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3448::AID-IMMU3448>3.0.CO;2-5","article-title":"Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for V\u03b124+ T cells and rapid elimination of effector cells by apoptosis","volume":"28","author":"Nuti","year":"1998","journal-title":"Eur J Immunol"},{"volume-title":"T lymphocytes in the Liver: Immunobiology, Pathology, and Host Defense","year":"1999","author":"Crispe","key":"10.1053\/jhep.2002.30293-BIB35|cit35"},{"key":"10.1053\/jhep.2002.30293-BIB36|cit36","first-page":"299","article-title":"Cell mediated immune response to the hepatitis C virus","volume":"242","author":"Rehermann","year":"2000","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1053\/jhep.2002.30293-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4049\/jimmunol.162.2.1156","article-title":"Identification of HLA-A3 and B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C","volume":"162","author":"Chang","year":"1999","journal-title":"J Immunol"},{"key":"10.1053\/jhep.2002.30293-BIB38|cit38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/hep.510250336","article-title":"Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection","volume":"15","author":"Hiroishi","year":"1997","journal-title":"Hepatology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1053%2Fjhep.2002.30293","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1053%2Fjhep.2002.30293","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200201000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T15:48:14Z","timestamp":1738943294000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200201000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002]]}},"URL":"https:\/\/doi.org\/10.1053\/jhep.2002.30293","relation":{},"ISSN":["0270-9139"],"issn-type":[{"type":"print","value":"0270-9139"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}